首页> 外文OA文献 >Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model

【2h】

Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model

机译：仓鼠肺栓塞模型中烟草注射液的比较血栓性能和嵌合（T-PA / U-PA）纤溶酶原激活剂的连续输注

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
HR Lu; HR Lijnen; JM Stassen; D Collen;
展开▼
作者单位

展开▼
年度 1991
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism [J] . Guner Ahmet, Kalcik Macit, Aykan Ahmet C., Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2020,第8期

机译：低剂量促血栓溶液促血栓素活化剂临床安全性和疗效治疗中高风险肺栓塞患者组织型纤溶酶原激活剂
2. Plasminogen activators (tissue type t-PA, urokinase type u-PA) and plasminogen activator inhibitor type 1 (PAI-1) in Graves disease [J] . Danuta Ro??, Ewa Zastawna, Wanda Drewniak, Medical science monitor : . 1998,第12期

机译：Graves病中的纤溶酶原激活物（组织型t-PA，尿激酶u-PA型）和纤溶酶原激活物抑制剂1（PAI-1）
3. Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW u-PA, HMW u-PA, and t-PA: Use of site-specific fluorescent probes of local environment. [J] . Backovic M, Stratikos E, Lawrence DA, Protein Science: A Publication of the Protein Society . 2002,第5期

机译：在丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂1和精氨酸特异性蛋白酶胰蛋白酶，LMW u-PA，HMW u-PA和t-PA之间形成的共价复合物的结构相似性：使用局部环境的位点特异性荧光探针。
4. A Mathematical Model of Plasminogen Activation and Fibrinogenolysis during Thrombolytic Therapy with t-PA [C] . Barbara Boniollo, Karl Thomaseth 1995 IEEE engineering in medicine and biology 17th annual conference and 21st Canadian medical and biological engineering conference . 1997

机译：t-PA溶栓治疗期间纤溶酶原激活和纤维蛋白原分解的数学模型
5. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. [O] . O F Wagner, C de Vries, C Hohmann, 1989

机译：与纤维蛋白结合的1型纤溶酶原激活物抑制剂（PAI-1）与组织型纤溶酶原激活物（t-PA）或尿激酶型纤溶酶原激活物（u-PA）之间的相互作用。 t-PA / PAI-1复合物与t-PA的手指和kringle-2结构域介导的纤维蛋白结合。
6. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu(a t-PA/u-PA Chimera) in a combined arterial and venous thrombosis model in the dog [O] . Kong Lu Hua, Wu Zaomin, Pauwels Patrick, 1992

机译：组织型纤溶酶原激活物（t-PA），单链尿激酶型纤溶酶原激活物（u-PA）和K1K2Pu（t-PA / u-PA Chimera）在动脉和静脉血栓联合模型中的比较溶栓特性那只狗

Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model

著录项

引文网络

相似文献

相关主题

期刊订阅